Atombeat & BioDuro Launch AI Platform to Speed Peptide Discovery
On July 30, 2025, Atombeat Inc., a leading force in AI for drug discovery, and BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organization (CRDMO), announced a strategic collaboration to an AI powered platform for accelerated peptide drug discovery. This collaboration brings together Atombeat’s in silico modeling expertise, AI-accelerated & data-driven design platform with BioDuro’s expertise in discovery chemistry, biology and…